NASDAQ:ENTX | Free Cash Flow | Entera Bio Ltd.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$3.09M$0.00-$3.09M
2025-12-31-$1.83M$27,000.00-$1.86M
2025-03-31-$1.4M$8,000.00-$1.41M
2024-12-31-$1.47M$3,000.00-$1.47M
2024-03-31-$1.86M$0.00-$1.86M
2023-12-31-$2.62M$5,000.00-$2.62M
2023-03-31-$1.61M$11,000.00-$1.62M
2022-12-31-$2.01M$3,000.00-$2.01M
2022-03-31-$4.79M$23,000.00-$4.82M
2021-12-31-$2.51M$10,000.00-$2.52M
2021-03-31-$2.32M$0.00-$2.32M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$7.37M$107,000.00-$7.48M
2024-12-31-$6.82M$3,000.00-$6.82M
2023-12-31-$7.31M$17,000.00-$7.33M
2022-12-31-$12.5M$47,000.00-$12.55M
2021-12-31-$9.06M$17,000.00-$9.08M
2020-12-31-$10.56M$53,000.00-$10.61M